Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone
{{output}}
Bone metastasis most commonly occurs in castration-resistant prostate cancer (CRPC). The TRPV6 calcium channel is absent in healthy prostate tissue, but its expression increases considerably during cancer progression. We hypothesized that cancer cells induce T... ...
